TW201600116A - Composition useful as external preparation for skin or cosmetic preparation - Google Patents
Composition useful as external preparation for skin or cosmetic preparation Download PDFInfo
- Publication number
- TW201600116A TW201600116A TW104109375A TW104109375A TW201600116A TW 201600116 A TW201600116 A TW 201600116A TW 104109375 A TW104109375 A TW 104109375A TW 104109375 A TW104109375 A TW 104109375A TW 201600116 A TW201600116 A TW 201600116A
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- oil
- composition
- skin
- component
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 21
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 10
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960003330 pentetic acid Drugs 0.000 claims abstract description 9
- 150000001768 cations Chemical class 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 43
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 9
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 6
- 239000002386 air freshener Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 description 76
- -1 trisodium ethoxide pentaacetate trisodium hydrate Chemical compound 0.000 description 43
- 239000003921 oil Substances 0.000 description 33
- 239000000284 extract Substances 0.000 description 31
- 239000004615 ingredient Substances 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000007864 aqueous solution Substances 0.000 description 29
- 238000004519 manufacturing process Methods 0.000 description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 27
- 238000011156 evaluation Methods 0.000 description 18
- PEYNTIPJBJDXCN-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O Chemical compound [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O PEYNTIPJBJDXCN-UHFFFAOYSA-N 0.000 description 17
- 239000003755 preservative agent Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000006210 lotion Substances 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 13
- 235000013599 spices Nutrition 0.000 description 13
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 9
- GWHJZXXIDMPWGX-UHFFFAOYSA-N 1,2,4-trimethylbenzene Chemical compound CC1=CC=C(C)C(C)=C1 GWHJZXXIDMPWGX-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 125000004494 ethyl ester group Chemical group 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000011787 zinc oxide Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000011859 microparticle Substances 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- 229960000984 tocofersolan Drugs 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 235000019489 Almond oil Nutrition 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- KHCCSRVJJDOANA-RQOBALISSA-N Labdanolic acid Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CC[C@H](C)CC(O)=O)[C@](C)(O)CC[C@H]21 KHCCSRVJJDOANA-RQOBALISSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 4
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 4
- 240000000912 Macadamia tetraphylla Species 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000008168 almond oil Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000001815 facial effect Effects 0.000 description 4
- 239000010419 fine particle Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000010466 nut oil Substances 0.000 description 4
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- WLRWTEIAYJHXDW-UHFFFAOYSA-N 2,2,3,3,4,4,4a,5,5,6-decamethyl-6H-cyclopenta[b]pyran Chemical compound CC1C=C2C(C(C(C(O2)(C)C)(C)C)(C)C)(C1(C)C)C WLRWTEIAYJHXDW-UHFFFAOYSA-N 0.000 description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 3
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 229960004106 citric acid Drugs 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000004137 magnesium phosphate Substances 0.000 description 3
- 229960002261 magnesium phosphate Drugs 0.000 description 3
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 3
- 235000010994 magnesium phosphates Nutrition 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XVULBTBTFGYVRC-HHUCQEJWSA-N sclareol Chemical compound CC1(C)CCC[C@]2(C)[C@@H](CC[C@](O)(C)C=C)[C@](C)(O)CC[C@H]21 XVULBTBTFGYVRC-HHUCQEJWSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000008347 soybean phospholipid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 240000001548 Camellia japonica Species 0.000 description 2
- 235000002548 Cistus Nutrition 0.000 description 2
- 241000984090 Cistus Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 239000008344 egg yolk phospholipid Substances 0.000 description 2
- 229940068998 egg yolk phospholipid Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940044949 eucalyptus oil Drugs 0.000 description 2
- 239000010642 eucalyptus oil Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000036561 sun exposure Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- ZGZUKKMFYTUYHA-HNNXBMFYSA-N (2s)-2-amino-3-(4-phenylmethoxyphenyl)propane-1-thiol Chemical compound C1=CC(C[C@@H](CS)N)=CC=C1OCC1=CC=CC=C1 ZGZUKKMFYTUYHA-HNNXBMFYSA-N 0.000 description 1
- ZFFGZCTVZNNVLP-UHFFFAOYSA-N (3-acetyloxy-2,2-dimethylpropyl) acetate Chemical compound CC(=O)OCC(C)(C)COC(C)=O ZFFGZCTVZNNVLP-UHFFFAOYSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- OTOIIPJYVQJATP-BYPYZUCNSA-N (R)-pantoic acid Chemical compound OCC(C)(C)[C@@H](O)C(O)=O OTOIIPJYVQJATP-BYPYZUCNSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- UTUIBVHZFWGLTH-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1.CN1CCCC1C1=CC=CN=C1 UTUIBVHZFWGLTH-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000005731 Bambusa membranacea Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000010736 Cisto canescente Nutrition 0.000 description 1
- 235000013306 Cistus creticus Nutrition 0.000 description 1
- 244000028508 Cistus creticus Species 0.000 description 1
- 235000005241 Cistus ladanifer Nutrition 0.000 description 1
- 240000008772 Cistus ladanifer Species 0.000 description 1
- 240000004483 Cistus salviifolius Species 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- XVULBTBTFGYVRC-UHFFFAOYSA-N Episclareol Natural products CC1(C)CCCC2(C)C(CCC(O)(C)C=C)C(C)(O)CCC21 XVULBTBTFGYVRC-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004869 Labdanum Substances 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 244000307609 Mangifera caesia Species 0.000 description 1
- LAEIZWJAQRGPDA-UHFFFAOYSA-N Manoyloxid Natural products CC1(C)CCCC2(C)C3CC=C(C)OC3(C)CCC21 LAEIZWJAQRGPDA-UHFFFAOYSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- VWBLQUSTSLXQON-UHFFFAOYSA-N N.[V+5] Chemical compound N.[V+5] VWBLQUSTSLXQON-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001092489 Potentilla Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010052891 Skin bacterial infection Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- VKTHZHSHTVVWPN-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.NCCNCCN VKTHZHSHTVVWPN-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000020739 avocado extract Nutrition 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- PNSDHQDPDMOPCP-UHFFFAOYSA-N dioctadecyl 2-hydroxybutanedioate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCCCC PNSDHQDPDMOPCP-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000014058 juice drink Nutrition 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000008308 lipophilic cream Substances 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- BEVGWNKCJKXLQC-UHFFFAOYSA-N n-methylmethanamine;hydrate Chemical class [OH-].C[NH2+]C BEVGWNKCJKXLQC-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940070805 p-chloro-m-cresol Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003287 riboflavins Chemical class 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 description 1
- SUBJHSREKVAVAR-UHFFFAOYSA-N sodium;methanol;methanolate Chemical compound [Na+].OC.[O-]C SUBJHSREKVAVAR-UHFFFAOYSA-N 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000015040 sparkling wine Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 229940093609 tricaprylin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- UYUUAUOYLFIRJG-UHFFFAOYSA-N tris(4-methoxyphenyl)phosphane Chemical compound C1=CC(OC)=CC=C1P(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 UYUUAUOYLFIRJG-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本發明與安定含有勞丹酸的組成物有關。本發明之組成物做為皮膚外用劑、化妝料、芳香劑或食品等是有用的。 The present invention relates to a composition containing dilatine. The composition of the present invention is useful as an external preparation for skin, a cosmetic, a fragrance, or a food.
屬於半日花科的Cistus landaniferus L.等的萃取物,具有很強的抑制黑色素產生的作用、細胞激活作用、抗菌作用,且發現那是基於勞丹酸的活性。勞丹酸的甲基或乙基酯型,以及進一步發現彼等之還原型均有同樣的活性(專利文獻1)。 The extract of Cistus landaniferus L. belonging to the genus Panicaceae has a strong inhibitory effect on melanin production, cell activation, and antibacterial action, and it is found to be based on the activity of labranic acid. The methyl or ethyl ester type of labranic acid and the reduced form of each of them have the same activity (Patent Document 1).
接著,有提案建議將勞丹酸類用於皮膚外用劑,做為美白用或抗衰老用來使用(專利文獻2及3)。進而有含有勞丹酸類之膠原蛋白促進劑的提案(專利文獻4)。而且關於勞丹酸類的製造,目前正在研究在工業上有利且便宜的製造方法(專利文獻5)。 Next, there is a proposal to use Laudanic acid as a skin external preparation for whitening or anti-aging (Patent Documents 2 and 3). Further, there is a proposal for a collagen promoter containing a labranic acid (Patent Document 4). Further, regarding the manufacture of the labyrin acid, a manufacturing method which is industrially advantageous and inexpensive (Patent Document 5) is currently being studied.
[專利文獻1]日本特開平11-302219號公報 [Patent Document 1] Japanese Patent Laid-Open No. Hei 11-302219
[專利文獻2]日本特開2003-300859號公報 [Patent Document 2] Japanese Patent Laid-Open Publication No. 2003-300859
[專利文獻3]日本特開2003-300860號公報 [Patent Document 3] Japanese Patent Laid-Open Publication No. 2003-300860
[專利文獻4]日本特開2005-8574號公報 [Patent Document 4] Japanese Patent Laid-Open Publication No. 2005-8574
[專利文獻5]日本特開2004-331571號公報 [Patent Document 5] Japanese Patent Laid-Open Publication No. 2004-331571
勞丹酸類的功能日益清楚,然而關於含有功能上有效的量的實用製劑的研究並不充分。根據本發明者群的研討發現,非常難以使勞丹酸類安定含有於製劑之中。並且發現尤其是含有功能上有效量之勞丹酸的組成物,在保存時會發生勞丹酸類變質、或變臭和濁度變化、浮油等情況。 The function of the labdanic acid is becoming increasingly clear, but research on practical preparations containing functionally effective amounts is not sufficient. According to the study of the inventors of the present invention, it has been found that it is very difficult to contain the labyrin acid stabilizer in the preparation. Further, it has been found that particularly a composition containing a functionally effective amount of labothenic acid may cause deterioration of the labranic acid, odor, turbidity change, oil slick, etc. during storage.
本發明者群反覆專注研討使勞丹酸類安定地含有於組成物中的方法。其結果為發現,藉由搭配特定的物質做為安定劑,提高勞丹酸類的經時安定性,並完成本項發明。 The inventors of the present invention have repeatedly focused on a method for stably containing the labyrin acid in the composition. As a result, it was found that the stability of the labyrin acid was improved by using a specific substance as a stabilizer, and the present invention was completed.
本發明提供如下。 The present invention is provided as follows.
[1]一種組成物,其特徵係含有:(A)以下述通式(1):
[2]如[1]之組成物,其中,含有(A)0.0001~5質量%。 [2] The composition according to [1], which contains (A) 0.0001 to 5% by mass.
[3]如[1]或[2]之組成物,其中,含有(B)0.005~2質量%。 [3] The composition according to [1] or [2], which contains (B) 0.005 to 2% by mass.
[4]如[1]~[3]中任一項之組成物,其中,(A)與(B)的含有質量比例(B)/(A)為0.01~40。 [4] The composition according to any one of [1] to [3], wherein the mass ratio (B)/(A) of (A) and (B) is 0.01 to 40.
[5]如[1]~[4]中任一項之組成物,其中,含有(C)油劑0.01~10質量%。 [5] The composition according to any one of [1] to [4] wherein the (C) oil agent is contained in an amount of 0.01 to 10% by mass.
[6]如[1]~[5]中任一項之組成物,其中,含有(D)低級醇。 [6] The composition according to any one of [1] to [5] which contains (D) a lower alcohol.
[7]如[1]~[6]中任一項之組成物,為皮膚外用劑或化 妝料。 [7] The composition according to any one of [1] to [6], which is a topical preparation for skin Makeup material.
[8]一種(A)的安定化方法,其特徵係使用 [8] A method of stabilization of (A), characterized in that it is used
相對於(A)以下述通式(1):
[9]如[8]之方法,安定化為包含抑制(A)的分解或抑制(A)的酯形成。 [9] The method according to [8], which is stabilized to include ester decomposition which inhibits decomposition of (A) or inhibits (A).
[10]一種(A)的安定化劑,其特徵係包含(B)。 [10] A stabilizer of (A) characterized by comprising (B).
[11]如[10]之劑,其特徵係為了抑制(A)的分解或抑制(A)的酯形成者。 [11] The agent according to [10], which is characterized in that it inhibits decomposition of (A) or inhibits formation of an ester of (A).
勞丹酸類藉由本發明被安定化。具體來說,藉由本發 明可維持組成物中勞丹酸類經時的殘存量。此外,含勞丹酸類組成物的隨時間發生的變臭與外觀變化也受到抑制。 Laudanic acid is stabilized by the present invention. Specifically, with this issue It is possible to maintain the residual amount of the labyrin acid in the composition over time. Further, the odor and appearance change of the composition containing the labousuric acid over time are also suppressed.
本說明書中,以「~」表示數值範圍時,包含該範圍兩端的數值。 In this manual, when "~" is used to indicate a numerical range, the values at both ends of the range are included.
本發明之組成物,含有成分(A)及成分(B)。 The composition of the present invention contains the component (A) and the component (B).
本發明以包含下述一般式(1)所代表之化合物1種或2種以上做為成分(A)。 In the present invention, one or two or more compounds represented by the following general formula (1) are used as the component (A).
通式(1)中,R1代表-CH2OH或-COOR6,R6代表氫、碳數1~3的低級烷基或可與-COO-形成鹽的陽離子,R2~R5各自獨立代表氫原子或甲基,‧‧‧A‧‧‧代表=C(CH3)-,-C(CH3)=,-C(=CH2)-,-CH(CH3)-或-C(OH)(CH3)-。前述碳數1~3的低級烷基,可以是直鏈型也可以是支鏈型。可舉出甲基、乙基、n-丙基、iso-丙基等做為這種烷基。而且,可舉出Na+、K+及NH4 +等做為可與-COO-形成鹽的陽離子。此外,於本發明中,提到「勞丹酸類」時, 除有特殊說明,指的是以上述通式(1)所表示的化合物。 In the formula (1), R 1 represents -CH 2 OH or -COOR 6 , and R 6 represents hydrogen, a lower alkyl group having 1 to 3 carbon atoms or a cation capable of forming a salt with -COO - , and each of R 2 to R 5 Independently representing a hydrogen atom or a methyl group, ‧‧‧A‧‧‧ represents =C(CH 3 )-, -C(CH 3 )=, -C(=CH 2 )-, -CH(CH 3 )- or - C(OH)(CH 3 )-. The lower alkyl group having 1 to 3 carbon atoms may be a linear type or a branched type. A methyl group, an ethyl group, an n-propyl group, an iso-propyl group or the like can be mentioned as such an alkyl group. Further, Na + , K + , NH 4 + or the like can be mentioned as a cation which can form a salt with -COO - . Further, in the present invention, the term "lauranic acid" is used to mean a compound represented by the above formula (1) unless otherwise specified.
成分(A),以依下述通式(2)所表示之勞丹酸的1種或2種以上構成為佳。 The component (A) is preferably one or two or more kinds of the labyrin acid represented by the following formula (2).
通式(2)中,三處虛線表示當中有一處為雙鍵,其他為單鍵。勞丹酸中,更具體地來說包含下述化合物。 In the general formula (2), three dotted lines indicate that one of them is a double bond, and the other is a single bond. Among the labousylic acids, more specifically, the following compounds are contained.
作為另一個通式(1)所包含的勞丹酸以外的化合物,較佳之例為勞丹酸還原型之下述化合物。 The compound other than the labothenic acid contained in the other formula (1) is preferably a compound of the following type of labranate.
以通式(1)表示之化合物,可藉由化學合成(例如,參考前述專利文獻5)和從植物萃取等而得。以通式(1)表示之化合物,也可做為植物萃取物(例如,Labdanum Absolute,瑞士奇華頓公司(Givaudan)製等)用於本發明之組成物。 The compound represented by the formula (1) can be obtained by chemical synthesis (for example, refer to the aforementioned Patent Document 5) and extraction from plants. The compound represented by the formula (1) can also be used as a composition of the present invention as a plant extract (for example, Labdanum Absolute , manufactured by Givaudan, etc.).
關於萃取出以通式(1)表示之化合物的植物種類,只要是包含該化合物的植物並無特殊限制,但以使用Cistus ladaniferus L.、Cistus creticus L.、Cistus monoperiensis L.、Cistus salvifolius(半日花科)的植物體特別有利。可單獨使用此等,也可將2種以上搭配使用。 Regarding the plant species in which the compound represented by the general formula (1) is extracted, there is no particular limitation on the plant containing the compound, but Cistus ladaniferus L., Cistus creticus L., Cistus monoperiensis L., Cistus salvifolius (half day) are used. The plant body of the flower family is particularly advantageous. These can be used alone or in combination of two or more.
於本發明之組成物,可將來自植物體的粗萃取物或市 售的萃取物直接當作(A)成分使用,也可從粗萃取物或市售的萃取物中精製出以前述通式(1)所表示之化合物當作(A)成分使用。例如,針對粗萃取物或市售的萃取物,在0.1~0.5mmHg的減壓下進行分子蒸餾,收集160℃~230℃之餾分,則此餾分中即包含勞丹基-7-烯-15-酸、勞丹基-8(17)-烯-15-酸、勞丹基-8-烯-15-酸的混合物。 可直接使用此等酸混合物當作(A)成分,也可視需要調製甲基、乙基等酯型、鹽、或還原型之後,使用彼等之混合物。可進一步將勞丹酸從此酸混合物分離出來。具體來說,將此酸混合物溶解於乙醇,在有催化劑量的硫酸共存的條件下使其反應成乙酯型,之後,以硝酸銀處理過的矽膠進行矽膠管柱層析處理。用己烷清洗管柱,接著以1%醋酸乙酯-己烷析出。以首先是勞丹基-8-烯-15-酸乙酯,接著是以勞丹基-7-烯-15-酸乙酯、勞丹基-8(17)-烯-15-酸乙酯的順序被析出。蒸餾除去溶劑,即可分別得到乙酯型的純品。藉由加水分解,可從所得的乙酯型得到游離酸。藉由進一步使游離酸和重氮甲烷反應可得到甲酯型。 以通式(1)表示之化合物的更詳細的製造方法可參考前述專利文獻1~5。 For the composition of the present invention, a crude extract or plant from a plant body can be used. The extract to be sold is used as the component (A) as it is, and the compound represented by the above formula (1) can be used as the component (A) by purifying the crude extract or the commercially available extract. For example, for a crude extract or a commercially available extract, molecular distillation is carried out under a reduced pressure of 0.1 to 0.5 mmHg, and a fraction of 160 ° C to 230 ° C is collected, and the fraction contains labronyl-7-ene-15. a mixture of acid, labdanyl-8(17)-ene-15-acid, labdanyl-8-ene-15-acid. These acid mixtures can be directly used as the component (A), and if necessary, an ester type, a salt, or a reduced form such as a methyl group or an ethyl group can be prepared, and a mixture thereof can be used. Laudanic acid can be further separated from the acid mixture. Specifically, the acid mixture was dissolved in ethanol, and reacted into an ethyl ester type under the condition that a catalytic amount of sulfuric acid coexisted, and then the tantalum-treated silica gel was subjected to a gel column chromatography. The column was washed with hexane and then precipitated with 1% ethyl acetate-hexane. First is labronyl-8-ene-15-acid ethyl ester, followed by labdanyl-7-ene-15-acid ethyl ester, labdanyl-8(17)-ene-15-acid ethyl ester The order is precipitated. The solvent was distilled off to obtain a pure ethyl ester type. The free acid can be obtained from the obtained ethyl ester type by hydrolysis. The methyl ester type can be obtained by further reacting the free acid with diazomethane. For a more detailed production method of the compound represented by the general formula (1), reference can be made to the aforementioned Patent Documents 1 to 5.
於本發明之組成物,成分(A)的含有量並無特殊限制,無論其他成分的含有量為何,都可考慮經濟性、溶解性、安定性等來決定,以0.0001~5質量%(於本發明,有時將質量%簡寫為「%」)為佳,0.001~1%較佳,0.01~0.5%更佳。因為此量可使勞丹酸類的功能有效地發揮,並 可藉後述成分(B)有效地求得勞丹酸類的安定化。此外,當包含2種以上的化合物做為成分(A)時,除有特殊說明,彼等化合物的總量即為做為成分(A)的含有量。其他成分亦同。 In the composition of the present invention, the content of the component (A) is not particularly limited, and may be determined in consideration of economy, solubility, stability, etc., regardless of the content of other components, and is 0.0001 to 5% by mass. In the present invention, the mass % is sometimes abbreviated as "%"), preferably 0.001 to 1%, more preferably 0.01 to 0.5%. Because this amount can make the function of the labdanic acid effective, and The stability of the labranic acid can be effectively obtained by the component (B) described later. In addition, when two or more types of compounds are contained as the component (A), the total amount of these compounds is the content of the component (A) unless otherwise specified. The other ingredients are the same.
本發明之組成物,可包含選自二伸乙三胺五乙酸及其鹽類所成群之1種或2種以上做為成分(B)。二伸乙三胺五乙酸為以下式表示之化合物。 The composition of the present invention may contain one or more selected from the group consisting of diethylenetriamine pentaacetic acid and salts thereof as component (B). Diethylenetriamine pentaacetic acid is a compound represented by the following formula.
根據本發明者群的研討發現,從勞丹酸類的經時維持、防止變臭、及防止濁度變化和浮油的觀點來看,使用二伸乙三胺五乙酸及其鹽類對勞丹酸類特別有效。焦亞硫酸鹽、及天然維生素E、二丁基羥基甲苯之類的脂溶性抗氧化劑沒有相同的效果,而且常被用來當作螯合劑的乙二胺四乙酸也沒有相同的效果。 According to the study of the inventors of the present invention, it was found that diamethylenetriamine pentaacetic acid and its salts are used for laboratories from the viewpoints of maintenance of time, prevention of odor, prevention of turbidity change and oil slick. Acids are particularly effective. The pyrosulfate, the fat-soluble antioxidant such as natural vitamin E and dibutylhydroxytoluene have no similar effect, and ethylenediaminetetraacetic acid which is often used as a chelating agent does not have the same effect.
可做為成分(B)使用之二伸乙三胺五乙酸的鹽類,只要是被容許用做醫藥、食品、化妝料或皮膚外用劑添加物者即無特殊限制,例如可舉出,鹼金屬的鹽、鹼土金屬的鹽、三級胺的鹽等。可舉出鈉鹽、鉀鹽為特別理想的例子。可視需要使用1種或2種以上做為成分(B)。此 外,本發明中提及「二伸乙三胺五乙酸及其鹽類」時,除有特殊說明,包含彼等之無水物及溶劑合物(例如二伸乙三胺五乙酸鈣三鈉水合物)。 The salt of diethylenetriamine pentaacetic acid which can be used as the component (B) is not particularly limited as long as it is allowed to be used as a medicine, food, cosmetic or external preparation for skin, and for example, a base is mentioned. a salt of a metal, a salt of an alkaline earth metal, a salt of a tertiary amine, or the like. A sodium salt or a potassium salt is particularly preferable. One or two or more kinds of components (B) may be used as needed. this In addition, when referring to "diethylenetriamine pentaacetic acid and its salts" in the present invention, unless otherwise specified, they include their anhydrates and solvates (for example, trisodium ethoxide pentaacetate trisodium hydrate) ()).
可用來作為本發明之組成物中的成分(B)的二伸乙三胺五乙酸及其鹽類,有在市面上販賣且容易取得。也可使用市售的二伸乙三胺五乙酸五鈉的約40%水溶液(約1.0mol/L)做為成分(B)。 Diethylenetriamine pentaacetic acid and salts thereof which can be used as the component (B) in the composition of the present invention are commercially available and are easily available. A commercially available solution of about 40% aqueous solution of pentasodium diethylenetriamine pentaacetate (about 1.0 mol/L) can also be used as the component (B).
於本發明之組成物,成分(B)的含有量並無特殊限制,可考慮經濟性、溶解性、安定性等,視該成分的螯合能力做適當的設計。以0.005~2%為佳,0.01~1%較佳,0.02~0.5%更佳,0.06~0.2%更佳。此等範圍的量特別適合當使用二伸乙三胺五乙酸五鈉做為成分(B)的情況。使用二伸乙三胺五乙酸五鈉以外的東西做為成分(B)時,亦可將上述量的範圍當作使用二伸乙三胺五乙酸五鈉,計算其等量來應用。 In the composition of the present invention, the content of the component (B) is not particularly limited, and economical, solubility, stability, and the like can be considered, and the chelating ability of the component can be appropriately designed. Preferably, 0.005~2% is preferred, 0.01~1% is preferred, 0.02~0.5% is better, and 0.06~0.2% is better. The amounts in these ranges are particularly suitable when using pentasodium diethylenetriamine pentaacetate as component (B). When a substance other than pentasodium diethylenetriamine pentaacetate is used as the component (B), the above amount can also be used as the equivalent amount using diamethylenediamine pentaacetic acid pentasodium.
無論其他成分量為何,關於成分(B)與成分(A)的含有質量比例皆可為(B)/(A)=0.01~40、以0.05~20為佳、0.1~10較佳、0.6~2較佳。因為在此範圍內成分(B)可充分地對成分(A)的安定化做出貢獻。 Regardless of the amount of other components, the mass ratio of the component (B) to the component (A) may be (B) / (A) = 0.01 to 40, preferably 0.05 to 20, 0.1 to 10, and 0.6. 2 is preferred. Since the component (B) within this range can sufficiently contribute to the stabilization of the component (A).
本發明之組成物可含有油劑做為成分(C)。勞丹酸類不被包含在本發明之成分(C)中。 The composition of the present invention may contain an oil agent as the component (C). Laudanic acid is not included in the component (C) of the present invention.
可做為本發明之組成物中成分(C)使用之油劑,只 要是被容許用作醫藥、食品、化妝料或皮膚外用劑添加物者即無特殊限制,無論液態、膏狀、固態的油劑都可使用。具體來說,液態油有植物油、烴油、合成或半合成酯油、矽油等,具體來說植物油有酪梨油、亞麻籽油、扁桃油、橄欖油、杏仁油、小麥胚芽油、芝麻油、米胚芽油、米糠油、紅花油、大豆油、玉米油、荷荷巴油、夏威夷果仁油、棉籽油、椰子油等,烴油有角鯊烷、液態石蠟等。 合成或半合成酯油可舉例有羊毛脂醇、乙酸羊毛脂、羊毛脂脂肪酸異丙酯、2-己基癸醇、單異硬脂酸N-烷基二醇、異硬脂酸、三異硬脂酸三羥甲基丙烷酯、二-2-乙基己酸乙二醇酯、2-乙基己酸鯨蠟酯、三-2-乙基己酸三羥甲基丙烷酯、四-2-乙基己酸季戊四醇酯、辛酸鯨蠟酯、油酸油醇酯、辛基十二烷基油酸酯、二癸酸新戊二醇酯、琥珀酸2-乙基己酯、硬脂酸異鯨蠟酯、硬脂酸丁酯、癸二酸二-2-乙基己酯、乳酸鯨蠟酯、乳酸肉荳蔻酯、蘋果酸二硬脂基酯、三異硬脂酸甘油酯、三-2-乙基己酸甘油酯、單硬脂酸甘油酯、二-2-庚基十一酸甘油酯、角鯊烷等,矽油可舉例有甲基聚矽氧烷、乙基聚矽氧烷、乙基甲基聚矽氧烷等。而且膏狀油可舉例有,在植物油有可可脂、乳油木果油、蓖麻油等,合成或半合成油可舉例有硬化蓖麻油、硬化椰子油、合成羊毛脂、單硬脂酸硬化蓖麻油、單羥基硬脂酸硬化蓖麻油、羥基硬脂酸膽固醇酯、二季戊四醇脂肪酸酯、N-月桂醯基-L-麩胺酸-二(膽固醇基.二十二烷基.辛基十二烷基)、夏威夷果仁油脂肪酸植物固醇酯、 烴油可舉例有凡士林等。固態油可舉例有,在植物油有,巴西棕櫚蠟、小燭樹蠟、蜜蠟等,烴油可舉例有地蠟、石蠟(paraffin)、石蠟(paraffin wax)、微晶蠟、硬脂酸、俞樹酸等、合成或半合成酯油可舉例有12-羥基硬脂酸、棕櫚酸鯨蠟酯、二硬脂酸聚乙二醇、三俞樹酸甘油酯等,這些油劑可視需要使用一種或二種以上。 It can be used as an oil agent for the component (C) in the composition of the present invention, If it is allowed to be used as an additive for medicines, foods, cosmetics or external preparations for skin, there is no particular limitation, and liquid, paste or solid oils can be used. Specifically, the liquid oil is vegetable oil, hydrocarbon oil, synthetic or semi-synthetic ester oil, eucalyptus oil, etc., specifically, vegetable oil is avocado oil, linseed oil, almond oil, olive oil, almond oil, wheat germ oil, sesame oil, Rice germ oil, rice bran oil, safflower oil, soybean oil, corn oil, jojoba oil, macadamia nut oil, cottonseed oil, coconut oil, etc., and hydrocarbon oils include squalane and liquid paraffin. The synthetic or semi-synthetic ester oil can be exemplified by lanolin alcohol, lanolin acetate, lanolin fatty acid isopropyl ester, 2-hexyl decyl alcohol, monoisostearic acid N-alkyl diol, isostearic acid, triiso-hard Trimethylolpropane fatty acid ester, ethylene glycol di-2-ethylhexanoate, cetyl 2-ethylhexanoate, trimethylolpropane tris-2-ethylhexanoate, four-2 - pentaerythritol ethylhexanoate, cetyl octylate, oleyl oleate, octyl lauryl oleate, neopentyl glycol dicaprate, 2-ethylhexyl succinate, stearic acid Isocetyl ester, butyl stearate, di-2-ethylhexyl sebacate, cetyl lactate, myristyl lactate, distearyl malate, glyceryl triisostearate, three 2-ethylhexanoic acid glyceride, glyceryl monostearate, di-2-heptyl undecanoic acid glyceride, squalane, etc., the eucalyptus oil can be exemplified by methyl polyoxyalkylene, ethyl polyoxyn Alkane, ethylmethyl polyoxyalkylene, and the like. Further, the creamy oil may, for example, be cocoa butter, shea butter, castor oil, etc. in the vegetable oil, and the synthetic or semi-synthetic oil may be exemplified by hardened castor oil, hardened coconut oil, synthetic lanolin, and monostearic acid hardened castor oil. , monohydroxystearic acid hardened castor oil, hydroxystearic acid cholesteryl ester, dipentaerythritol fatty acid ester, N-lauroyl-L-glutamic acid-di(cholesteryl.docosyl.octyl-12 Alkyl), macadamia nut oil fatty acid phytosterol ester, The hydrocarbon oil can be exemplified by petrolatum or the like. The solid oil may, for example, be a vegetable oil, a carnauba wax, a candelilla wax, a beeswax, etc., and the hydrocarbon oil may be exemplified by ceresin, paraffin, paraffin wax, microcrystalline wax, stearic acid, Examples of the synthetic or semi-synthetic ester oils such as eucalyptus acid include 12-hydroxystearic acid, cetyl palmitate, polyethylene glycol distearate, and glyceryl tristearate. These oils can be used as needed. One or more.
成分(C)的油劑於本發明之組成物中,為有助於勞丹酸類安定化者,然而因為本發明之組成物中藉由成分(B)求得勞丹酸類的安定化,所以可以較為自由地設計成分(C)的含有量。 The oil agent of the component (C) is a composition which contributes to the stability of the labdanic acid in the composition of the present invention. However, since the composition of the present invention determines the stability of the labdanic acid by the component (B), The content of the component (C) can be designed relatively freely.
使本發明之組成物中含有成分(C)時,上限值,無論其他成分的含有量為何,舉例來說可為10%以下,也可為1%以下,也可為0.5%以下。下限值可適當設計,但無論其他成分的含有量為何,舉例來說可為0.01%以上,也可為0.05%以上,而且也可為0.1%以上。因為在此範圍內不會損及本發明藉成分(B)將成分(A)安定化的效果。 When the component (C) is contained in the composition of the present invention, the upper limit value may be, for example, 10% or less, or 1% or less, or 0.5% or less, regardless of the content of the other components. The lower limit can be appropriately designed, but it may be, for example, 0.01% or more, 0.05% or more, or 0.1% or more, regardless of the content of other components. Since the effect of the component (A) is stabilized by the component (B) of the present invention is not impaired in this range.
本發明之組成物可含有低級醇做為成分(D)。低級醇會與勞丹酸類形成酯,因此有對勞丹酸類的安定性不利的可能性,但本發明之組成物中藉由成分(B)求得勞丹酸類的安定化。所謂低級醇是指碳數2~5的直鏈或支鏈醇。 The composition of the present invention may contain a lower alcohol as the component (D). Since the lower alcohol forms an ester with Laodanic acid, it may be disadvantageous to the stability of the labranic acid. However, in the composition of the present invention, the stability of the labranic acid is determined by the component (B). The lower alcohol refers to a linear or branched alcohol having 2 to 5 carbon atoms.
可做為成分(D)使用的低級醇,只要是被容許做為醫藥、食品、化妝料或皮膚外用劑添加物者即無特殊限制。例如可舉出,乙醇、正丙醇、異丙醇、正丁醇等。特佳的例子為乙醇。可視需要使用一種或混合使用二種以上做為成分(D)。 The lower alcohol which can be used as the component (D) is not particularly limited as long as it is allowed to be added as a medicine, a food, a cosmetic or an external preparation for skin. For example, ethanol, n-propanol, isopropanol, n-butanol, etc. are mentioned. A particularly good example is ethanol. One or a mixture of two or more may be used as the component (D) as needed.
本發明之組成物中成分(D)的含有量,無論其他成分的含有量為何,舉例來說為,0.5~50%,以1~30%為佳,2~15%較佳。因為在此範圍內不會損及本發明藉成分(B)將成分(A)安定化的效果。 The content of the component (D) in the composition of the present invention is, for example, 0.5 to 50%, preferably 1 to 30%, and preferably 2 to 15%, regardless of the content of the other components. Since the effect of the component (A) is stabilized by the component (B) of the present invention is not impaired in this range.
本發明之組成物中,除了上述成分以外,還有被容許做為醫藥、食品、化妝料或皮膚外用劑添加物之各種成分,例如,此例為,水(純水、溫泉水、海洋深層水等)、界面活性劑(乳化劑、助溶劑、懸浮劑、安定劑等)、抗氧化劑、防腐劑、膠化劑、醇類、皮膜形成劑、色素、香料、除臭劑、鹽類、pH調節劑、清涼劑、螯合劑、角質溶解劑、酵素、維生素類等。從此等之中,將具體者舉例如下。 In the composition of the present invention, in addition to the above components, various components which are allowed to be added as medicine, food, cosmetic or external preparation for skin, for example, water (pure water, hot spring water, deep ocean) are also included. Water, etc., surfactants (emulsifiers, solubilizers, suspending agents, stabilizers, etc.), antioxidants, preservatives, gelling agents, alcohols, film forming agents, pigments, perfumes, deodorants, salts, pH regulator, cooling agent, chelating agent, keratolytic agent, enzyme, vitamins, etc. From among these, specific examples are as follows.
界面活性劑是用做油劑等的乳化和助溶等,可使用陰離子性、陽離子性、非離子性及兩離子性的活性劑。 The surfactant is used for emulsification and solubilization of an oil agent or the like, and an anionic, cationic, nonionic, and ionic active agent can be used.
無論是化學合成品或來自天然品,可做為增稠劑者為羧基乙烯聚合物、鹿角菜膠、洋菜、黃原膠、糊精脂肪酸酯、有機改質黏土礦物等。而且,此等成分不僅可用於調 整系統的黏度,還可用在膠化、保濕、形成皮膜等。 Whether it is a chemical synthetic product or a natural product, it can be used as a thickener as a carboxyvinyl polymer, carrageenan, agar, xanthan gum, dextrin fatty acid ester, organically modified clay mineral, and the like. Moreover, these ingredients can be used not only for tune The viscosity of the whole system can also be used for gelling, moisturizing, and forming a film.
做為粉體,可無論形狀和粒子的大小、有無多孔性、結晶構造等,為了提升使用性和使用感,也可為做過複合化和表面處理者。可視用途使用滑石、雲母、絹雲母、無水矽酸等無機粉體、尼龍粉末等有機粉體、魚鱗箔、氧氯化鉍等珍珠顏料、氧化鐵、碳黑、群青等無機顏料、焦油色素及其沉澱色料、天然色素、氧化鈦、微粒子氧化鈦、氧化鋅、微粒子氧化鋅等。尤其是一旦含有微粒子氧化鈦和微粒子氧化鋅,可更加提升本發明之效果,因此為理想的。 As the powder, regardless of the shape and size of the particles, the presence or absence of porosity, the crystal structure, etc., in order to improve the usability and the feeling of use, it is also possible to perform the compounding and surface treatment. For use, talc, mica, sericite, anhydrous citric acid and other inorganic powders, nylon powder and other organic powders, fish scale foil, bismuth oxychloride and other pearl pigments, iron oxide, carbon black, ultramarine and other inorganic pigments, tar pigments and The precipitated color, natural pigment, titanium oxide, fine particle titanium oxide, zinc oxide, fine particle zinc oxide, and the like. In particular, once the fine particle titanium oxide and the fine particle zinc oxide are contained, the effect of the present invention can be further enhanced, which is preferable.
為了防止系統中成分品質的劣化,除了成分(B),也可進一步使用EDTA等螯合劑、乳酸-乳酸鈉等緩衝劑為pH調整劑。 In addition to the component (B), a buffer such as EDTA or a buffer such as lactic acid-sodium lactate may be further used as the pH adjuster in order to prevent deterioration of the component quality in the system.
可舉出維生素、賀爾蒙、包含來自動植物和微生物萃取物的各種成分做為藥效劑,例如,抗菌劑是以預防和改善粉刺為目的而使用,可舉出安息香酸、安息香酸鈉、對羥基苯甲酸酯、對氯間甲酚、氯化苯二甲羥銨、苯氧乙醇、異丙基甲基酚等。藉由搭配此等成分,可抑制因粉刺等細菌性皮膚炎所引起的色素沉澱,並進一步發揮高效美白及/或美膚效果及抗衰老效果。活性氧去除劑是以抑制紫外線引起的過氧化脂質生成等為目的而使用,可舉出超氧化物歧化酶、兒茶素及其衍生物、噻胺類(鹽酸噻胺、硫酸噻胺)、核黃素類(核黃素、醋酸核黃素等)、吡哆醇類(鹽酸吡哆醇、吡哆二辛酸酯等)、菸鹼酸類(菸鹼 酸醯胺、菸鹼酸芣酯等)等維生素B類。藉由搭配此等活性氧去除劑,可抑制黯沉、發揮較高效美白及/或美膚效果及抗衰老效果。血液循環促進劑是以經由促進皮膚的血流而促進黑色素排出為目的而使用,可舉出辣椒酊、γ-米糠醇等、可舉出脂肪酶、木瓜酶等做為酵素。藉由搭配此等成分,可進一步發揮高效美白及/或美膚效果。 Examples thereof include vitamins, hormones, and various components containing automatic plant and microbial extracts. For example, antibacterial agents are used for the purpose of preventing and improving acne, and benzoic acid and sodium benzoate may be mentioned. Parabens, p-chloro-m-cresol, chlorinated dimethylammonium hydroxide, phenoxyethanol, isopropylmethylphenol, and the like. By combining these ingredients, it is possible to suppress pigmentation caused by bacterial dermatitis such as acne, and further exert an effective whitening and/or skin-beautifying effect and anti-aging effect. The active oxygen scavenger is used for the purpose of suppressing the production of lipid peroxide by ultraviolet rays, and examples thereof include superoxide dismutase, catechin and derivatives thereof, thiamines (thioamine hydrochloride, thiamine sulfate), Riboflavins (riboflavin, riboflavin acetate, etc.), pyridoxine (pyridoxine hydrochloride, pyridinium dioctanoate, etc.), nicotinic acid (nicotine) Vitamin B such as acid amide, niacin phthalate, etc. By using these active oxygen removers, it is possible to suppress stagnation, exert a more effective whitening and/or skin-beautifying effect and anti-aging effect. The blood circulation promoting agent is used for the purpose of promoting the discharge of melanin by promoting blood flow to the skin, and examples thereof include capsicum and γ-mysterol, and examples thereof include lipase and papain. By combining these ingredients, you can further exert effective whitening and/or skin-beautifying effects.
藉由搭配使用以進一步提升本發明之效果的其他成分可舉出,蛋白質或其衍生物或者加水分解物及其鹽類(膠原蛋白、彈力蛋白、角蛋白等)、黏多醣及其衍生物(玻尿酸、硫酸軟骨素等)、胺基酸及其衍生物(組胺酸、絲胺酸、甘胺酸、茶胺酸、天門冬胺酸、精胺酸、吡咯啶酮羧酸等)、糖類(山梨糖醇、赤藻糖醇、海藻糖、肌醇、葡萄糖、木糖醇、蔗糖及其衍生物、糊精及其衍生物、蜂蜜等)、D-泛酸醇及其衍生物、糖脂質、腦醯胺、明日葉萃取物、酪梨萃取物、溫泉水、錦葵萃取物、蕁麻萃取物、芒柄花屬萃取物、燕麥萃取物、梔子萃取物、山白竹萃取物、牛蒡萃取物、小麥萃取物、肥皂草萃取物、繡線菊萃取物、薑萃取物、西洋薄荷(薄荷)萃取物、立麝香草(百里香)萃取物、山茶花萃取物、直立委陵菜萃取物、香芹萃取物、薄荷萃取物、北美金縷梅萃取物、玫瑰萃取物、柏樹萃取物、向日葵萃取物、假葉樹萃取物、黑棗萃取物、絲瓜萃取物、菩提樹萃取物、松樹萃取物、榲桲萃取物、黏蛋白、矢車菊萃取物、薰衣草萃取物、蘋果萃取物、龍膽(龍膽草)萃取物等。藉由更進一步配合具 有皮膚表面密封效果的荷荷芭油、夏威夷果仁油、橄欖油、杏仁油、桃仁油、紅花油、葵花籽油、酪梨油、白芒花籽油、山茶籽油、扁桃油、白蘇油、芝麻油、Borage(琉璃苣)油、可可脂、乳油木果脂等,可發揮較高效美白及/或美膚效果,並期待實現具有透明感的肌膚(括號內記載植物的別名、中藥名等)。 Other components which further enhance the effects of the present invention by use together include proteins or derivatives thereof or hydrolysates and salts thereof (collagen, elastin, keratin, etc.), mucopolysaccharides and derivatives thereof ( Hyaluronic acid, chondroitin sulfate, etc., amino acids and derivatives thereof (histamine, serine, glycine, theanine, aspartic acid, arginine, pyrrolidone carboxylic acid, etc.), sugars (sorbitol, erythritol, trehalose, inositol, glucose, xylitol, sucrose and its derivatives, dextrin and its derivatives, honey, etc.), D-pantoic acid and its derivatives, glycolipids , ceramide, tomorrow leaf extract, avocado extract, hot spring water, mallow extract, ramie extract, formononet extract, oat extract, hazelnut extract, mountain white bamboo extract, burdock extract , wheat extract, saponin extract, spirea extract, ginger extract, western mint (mint) extract, thyme (thyme) extract, camellia extract, erect potentilla extract, incense Parsley extract, peppermint extract, North American witch hazel , rose extract, cypress extract, sunflower extract, fake leaf tree extract, black dates extract, loofah extract, linden extract, pine extract, alfalfa extract, mucin, cornflower extract, lavender extract , apple extract, gentian (gentiana) extract, etc. By further fitting Jojoba oil, macadamia nut oil, olive oil, almond oil, peach kernel oil, safflower oil, sunflower oil, avocado oil, white mango seed oil, camellia seed oil, almond oil, white Su oil, sesame oil, Borage oil, cocoa butter, shea butter, etc., can exert a more effective whitening and/or skin-beautifying effect, and look forward to achieving a translucent skin (alias of plants, Chinese medicines in parentheses) Name, etc.).
本發明之組成物,可以通常方法製造。典型的方法為,將成分(B)添加溶解於水溶性成分的混合物後,將含有成分(A)的油性成分均勻混合後的東西一邊攪拌一邊添加進去。 The composition of the present invention can be produced by a usual method. In a typical method, the component (B) is added to a mixture of the water-soluble components, and the oily component containing the component (A) is uniformly mixed and added while stirring.
藉由本發明而得到之組成物,即使經過長時間的保存,成分(A)仍無變質且能維持含有量,而且變臭與外觀的變化受到抑制。安定化的程度,若是本業者,根據適用於化妝料或皮膚外用劑等的現有方法及判斷基準,可做適當判斷。例如,可藉由比較在50℃保管一個月時的勞丹酸殘存量與初始值做出評價。此時,若勞丹酸類能維持95%以上不分解,則可評價為極安定。此外,變臭與製劑的安定性(濁度變化、浮油)可由專家進行的感官評價來判斷。此外,在相對透明的劑型的情況下,外觀的變化可用吸光率的值進行評價。 The composition obtained by the present invention does not deteriorate and maintains the content of the component (A) even after long-term storage, and the change in odor and appearance is suppressed. The degree of stability can be appropriately determined according to the existing methods and judgment criteria applicable to cosmetics or external preparations for skin. For example, the evaluation can be made by comparing the residual amount of labothenic acid at the time of storage at 50 ° C for one month and the initial value. At this time, if the labothelic acid can be maintained at 95% or more without decomposition, it can be evaluated as extremely stable. Further, the odor and the stability of the preparation (turbidity change, oil slick) can be judged by sensory evaluation by an expert. Further, in the case of a relatively transparent dosage form, the change in appearance can be evaluated by the value of the absorbance.
本發明之組成物,可做成化妝料或皮膚外用劑。且本發明之組成物的型態並無特殊限制,例如,可舉化妝水,水包油型或油包水型乳液,美容液,按摩材料,面膜材料等為例說明。本發明之皮膚外用劑,為美膚用之皮膚外用劑,尤其是做為美白用皮膚外用劑及/或抗衰老用皮膚外用劑是優異的。此外,本說明書中「美膚」一詞,有必要包含,例如,抑制色素沉澱、肌膚黯沉、防止及改善因日曬等的皮膚變黑、防止及改善斑、雀斑、皺紋等做最廣義的解釋,「美白」及「抗衰老」應理解為被包含在此範圍內。 The composition of the present invention can be used as a cosmetic or an external preparation for skin. Further, the form of the composition of the present invention is not particularly limited, and examples thereof include a lotion, an oil-in-water type or a water-in-oil type emulsion, a beauty liquid, a massage material, and a mask material. The skin external preparation of the present invention is an external preparation for skin for skin care, and is particularly excellent as a skin external preparation for skin whitening and/or an external preparation for skin anti-aging. In addition, the term "beauty skin" in this manual is necessary to include, for example, inhibiting pigmentation, skin dryness, preventing and improving skin blackening due to sun exposure, preventing and improving spots, freckles, wrinkles, etc. The interpretation of "whitening" and "anti-aging" should be understood as being included in this scope.
本發明之組成物亦可,視其使用目的,調配成固態劑、半固態劑、液劑等各種劑型的組成物。通常,在黏度低的液體中,由於組成物容易流動、油性成分少,所以成分(A)的安定性差。然而藉由本發明,即使是黏度相對較低的劑型,成分(A)仍無變質且能維持含有量,而且變臭與外觀的變化受到抑制。因此,本發明之組成物,可做成包括黏度相對較低的化妝水之類的東西在內的各種劑型。更具體地來說,本發明之組成物,做為基礎化妝品,可做成潔面劑、洗面乳、化妝水、乳液、乳霜、按摩產品、面膜產品、美容液.凝膠、唇部護理商品等;做為底妝化妝品,可做成粉底、蜜粉、妝前乳、遮瑕膏等;做為重點彩妝化妝品,可做成口紅、唇蜜.唇線筆、腮紅產 品、眼影、眼線筆、睫毛膏、眉筆產品等;做為身體用化妝品,可做成香皂、液體清潔劑、防曬霜、浴用劑等;做為頭髮用或頭皮用化妝品,可做成洗髮精、潤絲精、護髮乳、造型劑、頭髮滋養液、生髮劑、頭皮護理等。而且可做成,硬膏劑、軟膏劑、貼敷劑、搽劑、洗劑、塗佈劑、貼附劑、氣膠劑(噴霧藥)。 The composition of the present invention may be formulated into a composition of various dosage forms such as a solid agent, a semi-solid agent, and a liquid agent depending on the purpose of use. In general, in a liquid having a low viscosity, since the composition easily flows and the oil component is small, the stability of the component (A) is poor. However, according to the present invention, even in a dosage form having a relatively low viscosity, the component (A) does not deteriorate and maintains the content, and the change in odor and appearance is suppressed. Therefore, the composition of the present invention can be made into various dosage forms including a lotion having a relatively low viscosity. More specifically, the composition of the present invention, as a basic cosmetic, can be used as a cleansing agent, facial cleanser, lotion, lotion, cream, massage products, facial mask products, beauty liquid. Gel, lip care products, etc.; as a base makeup, can be made into foundation, powder, makeup before the milk, concealer, etc.; as a key makeup cosmetics, can be made into lipstick, lip gloss. Lip liner, blush Products, eye shadows, eyeliner, mascara, eyebrow pencil products, etc.; as a body cosmetics, can be made into soap, liquid detergent, sunscreen, bathing agent, etc.; as a hair or scalp cosmetics, can be made into a wash Hair essence, moisturizing essence, hair care lotion, styling agent, hair nourishing liquid, hair growth agent, scalp care, etc. Moreover, it can be made into a plaster, an ointment, a patch, an elixir, a lotion, a coating agent, a patch, and a gel (spray).
而且本發明之組成物可以做成,套件或包裝產品。除了本發明之組成物以外,此等方案還可包含使用方法和記載如上述目的之效果.效能者(例如,盒子、容器、標籤、使用說明書、吊牌)。 Moreover, the compositions of the present invention can be made into kits or packaged products. In addition to the compositions of the present invention, such protocols may also include methods of use and effects such as those described above. Effective person (for example, box, container, label, instruction manual, tag).
本發明之組成物可做成食品組成物。本發明中提及食品時,除了固態食品還包含液態食品(例如,湯、飲劑、飲料)。而且,包含特定保健用食品、健康食品、機能食品。做為食品組成物的具體形態,可舉例有,錠劑、膠囊劑、丸劑;糕點、麵包、優酪乳、果凍、冷凍甜點、糖果、口香糖;綠茶、烏龍茶、紅茶等茶飲料;蘋果汁、葡萄柚汁、柳橙汁等果汁類;搭配果汁飲料;搭配蔬菜汁飲料;咖啡飲料;可可飲料;牛奶等乳飲料;可樂、汽水等碳酸飲料;運動飲料;豆奶;礦泉水;清涼飲料水飲料;減肥飲料;營養補給飲料;啤酒、氣泡酒、紅酒、日本酒等酒精飲料。 The composition of the present invention can be made into a food composition. When referring to foods in the present invention, in addition to solid foods, liquid foods (for example, soups, drinks, beverages) are also included. Furthermore, it includes specific health foods, health foods, and functional foods. As a specific form of the food composition, a tablet, a capsule, a pill, a pastry, a bread, a yogurt, a jelly, a frozen dessert, a candy, a chewing gum, a tea beverage such as green tea, oolong tea, and black tea; apple juice, Grapefruit juice, orange juice and other juices; with juice drinks; with vegetable juice drinks; coffee drinks; cocoa drinks; milk and other milk drinks; carbonated drinks such as cola and soda; sports drinks; soy milk; mineral water; Dietary drinks; nutritional supplements; alcoholic beverages such as beer, sparkling wine, red wine, Japanese sake.
本發明之組成物可做成芳香劑組成物。本發明之芳香劑組成物可做成液態、半固態或固態。做為芳香劑組成物的具體形態,可舉例有香膏、薰香棒、室內芳香劑等。 The composition of the present invention can be used as a fragrance composition. The fragrance composition of the present invention can be made into a liquid state, a semi-solid state or a solid state. As a specific form of the composition of the fragrance, there may be mentioned a balm, an aroma stick, an indoor fragrance, and the like.
接下來舉出參考例、試驗例及實施例將本發明做更詳細的說明,但本發明並不受此等任何限制。 Hereinafter, the present invention will be described in more detail with reference to the examples, test examples and examples, but the invention is not limited thereto.
勞丹酸可依照前述專利文獻5的方法來製造。即,以市售的香紫蘇醇(分子式:C20H36O2,分子量:308.499,CAS No.:515-03-7)為起始物質。將硼酸、1-丁醇、甲苯、釩(V)酸銨加入起始物質中,經過氮置換後,在攪拌下添加碳酸鈉水溶液。加熱,並一邊去除產生的水一邊慢慢提高反應溫度,在140℃反應數小時。反應結束後,冷卻,添加NaOH水溶液,將產生的硼酸酯進行水解並分液分離。接著,在減壓下藉由加熱回收1-丁醇與甲苯。將1,2,4-三甲基苯加入其中,藉由用水洗滌數次取得烯丙基伯醇化合物。 Laudanic acid can be produced according to the method of the aforementioned Patent Document 5. Namely, a commercially available sclareol (molecular formula: C 20 H 36 O 2 , molecular weight: 308.499, CAS No.: 515-03-7) was used as a starting material. Boric acid, 1-butanol, toluene, and ammonium vanadium (V) were added to the starting material, and after replacement with nitrogen, an aqueous solution of sodium carbonate was added with stirring. The mixture was heated and the reaction temperature was gradually raised while removing the generated water, and the reaction was carried out at 140 ° C for several hours. After completion of the reaction, the mixture was cooled, and an aqueous NaOH solution was added thereto, and the produced boric acid ester was hydrolyzed and separated by liquid separation. Next, 1-butanol and toluene were recovered by heating under reduced pressure. 1,2,4-Trimethylbenzene was added thereto, and the allyl primary alcohol compound was obtained by washing several times with water.
將所得之烯丙基伯醇化合物的1,2,4-三甲基苯溶液置於反應容器,經過氮置換後,將反應液溫度調至31℃,添加〔RuCl2(對-甲基異丙基苯)〕與三(4-甲氧苯基)膦,經過氮置換後,加熱,在170~180℃反應數小時。然後,冷卻並當作反應結束,取得醛化合物。 The obtained allyl primary alcohol compound in 1,2,4-trimethylbenzene solution was placed in a reaction vessel, and after nitrogen substitution, the temperature of the reaction solution was adjusted to 31 ° C, and [RuCl 2 (p-methyl group) was added. Propylbenzene) and tris(4-methoxyphenyl)phosphine are replaced by nitrogen, heated, and reacted at 170 to 180 ° C for several hours. Then, it was cooled and treated as a reaction to obtain an aldehyde compound.
醛化合物的1,2,4-三甲基苯溶液,添加醋酸、H2NSO2OH、水之後,冷卻至-5℃,接著滴入80% NaClO2水溶液。放置數小時反應後,滴入20% Na2SO3水溶液。 其後藉由在40~50℃下攪拌30分鐘,將過氧化物分解。分液分離後,以5%食鹽水洗滌,取得羥基羧酸化合物。 The 1,2,4-trimethylbenzene solution of the aldehyde compound was added with acetic acid, H 2 NSO 2 OH, and water, and then cooled to -5 ° C, followed by dropwise addition of an 80% NaClO 2 aqueous solution. After standing for several hours, a 20% aqueous solution of Na 2 SO 3 was added dropwise. Thereafter, the peroxide was decomposed by stirring at 40 to 50 ° C for 30 minutes. After separation by liquid separation, the mixture was washed with 5% aqueous sodium chloride to obtain a hydroxycarboxylic acid compound.
對所得之羥基羧酸化合物的1,2,4-三甲基苯溶液加入20%硫酸水溶液,在加熱回流下於170℃~176℃一邊將水去除一邊進行數小時脫水反應。反應結束後,冷卻,加入28%甲醇鈉甲醇溶液,將羧酸轉成鈉鹽。將水加入其中,除去上層,將下層以庚烷洗滌數次後,加入庚烷與20%硫酸水溶液,將游離的羧酸萃取至庚烷層。進行減壓蒸餾,取得勞丹基-8-烯-15-酸、勞丹基-7-烯-15-酸及勞丹基-8(17)-烯-15-酸混合物(以下,提到「從製造例1得到的勞丹酸」時指的即為此物)。 To the 1,2,4-trimethylbenzene solution of the obtained hydroxycarboxylic acid compound, a 20% sulfuric acid aqueous solution was added, and the dehydration reaction was carried out for several hours while removing water while heating under reflux at 170 ° C to 176 ° C. After completion of the reaction, it was cooled, and a 28% sodium methoxide methanol solution was added to convert the carboxylic acid into a sodium salt. Water was added thereto, the upper layer was removed, and the lower layer was washed several times with heptane, then heptane and a 20% aqueous sulfuric acid solution were added, and the free carboxylic acid was extracted to a heptane layer. Distillation under reduced pressure to obtain a mixture of labdanyl-8-ene-15-acid, labdanyl-7-ene-15-acid and labdanyl-8(17)-ene-15-acid (hereinafter, mentioned "Lauronic acid obtained in Production Example 1" means "the object").
依照表1所示比例製造比較例1~5及實施例1~6。製造方法如下。 Comparative Examples 1 to 5 and Examples 1 to 6 were produced in accordance with the ratios shown in Table 1. The manufacturing method is as follows.
A.將成分(1)~(7),成分(8)~(9)各自溶解後混合。 A. The components (1) to (7) and the components (8) to (9) are each dissolved and mixed.
B.將成分(10)~(17)混合均勻後,一邊攪拌一邊添加至A。 B. The components (10) to (17) are uniformly mixed, and then added to A while stirring.
C.脫泡後得到化妝料。 C. A cosmetic is obtained after defoaming.
依照以下所示之方法及基準進行評價。 The evaluation was carried out according to the methods and criteria shown below.
將50℃保管一個月時的勞丹酸殘存量與初期值做比較。以HPLC測量峰值強度。從校正曲線算出殘存率。 The amount of labothenic acid remaining at 50 ° C for one month was compared with the initial value. The peak intensity was measured by HPLC. The residual rate is calculated from the calibration curve.
○殘存率95%以上 ○ Residual rate of 95% or more
△殘存率90%以上 未達95% △ residual rate of 90% or more, less than 95%
×殘存率未達90% × residual rate is less than 90%
將50℃一個月的保管品的氣味與室溫一個月的保管品的氣味做比較。由香料評價專業評判小組一人進行評價。 The odor of the storage product at 50 ° C for one month was compared with the odor of the storage product at room temperature for one month. The evaluation was conducted by a panel of experts in the evaluation of spices.
○無變化 ○ no change
△僅有少許變化 △ only a few changes
×有變化 ×Change
將化妝料裝入玻璃瓶中,觀察在50℃一個月保管後的製劑的安定性(濁度變化、浮油)。由化妝料評價專業評判小組一人進行評價。 The cosmetic was placed in a glass bottle, and the stability (turbidity change, oil slick) of the preparation after storage at 50 ° C for one month was observed. The evaluation was conducted by a panel of cosmetic evaluation experts.
○濁度變化與浮油均無 ○No change in turbidity or oil slick
△有濁度變化,但無浮油 △has turbidity change, but no oil slick
×有浮油 ×With oil slick
結果示於表1。 The results are shown in Table 1.
由表1可知,與廣泛使用的抗氧化劑焦亞硫酸鈉、螯合劑乙二胺四乙酸二鈉、脂溶性抗氧化劑天然維生素E及二丁基羥基甲苯相比,二伸乙三胺五乙酸五鈉抑制勞丹酸殘存率低下的效果非常優良。而且,在抑制變臭、濁度變化和浮油方面也非常優良。 It can be seen from Table 1 that compared with the widely used antioxidant sodium metabisulfite, the chelating agent disodium edetate, the fat-soluble antioxidant natural vitamin E and dibutylhydroxytoluene, the inhibition of pentasodium diethylenetriamine pentaacetate The effect of low residual rate of labranic acid is very good. Moreover, it is also excellent in suppressing odor, turbidity change, and oil slick.
將下述成分(1)~(13)在70℃下加熱混合製得洗面乳。 The following ingredients (1) to (13) were heated and mixed at 70 ° C to obtain a facial cleanser.
(成分) (%) (ingredient) (%)
(1)N-椰子油脂醯-L-麩胺酸三乙醇胺 20.0 (1) N-coconut oil 醯-L-glutamic acid triethanolamine 20.0
(2)月桂基二甲胺基乙酸甜菜鹼 10.0 (2) Lauryl dimethylaminoacetate betaine 10.0
(3)椰子油脂肪酸二乙醇酰胺 3.0 (3) Coconut oil fatty acid diethanolamide 3.0
(4)椰子油脂肪酸鉀 5.0 (4) Coconut oil fatty acid potassium 5.0
(5)硬脂酸 2.0 (5) Stearic acid 2.0
(6)甘油 20.0 (6) Glycerin 20.0
(7)聚乙二醇400 5.0 (7) Polyethylene glycol 400 5.0
(8)赤藻糖醇 2.0 (8) erythritol 2.0
(9)丙二醇 10.0 (9) Propylene glycol 10.0
(10)防腐劑 適量 (10) Preservatives
(11)二伸乙三胺五乙酸五鈉40%水溶液 1.0 (11) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 1.0
(12)於製造例1所得之勞丹酸 0.5 (12) Laudanic acid obtained in Production Example 1 0.5
(13)純水 殘餘量 (13) pure water residual amount
將下述成分(1)~(9)加熱混合至70℃。於此混合物中添加混合在70℃下加熱混合之(10)~(13)及(18),冷卻,進一步添加混合(14)~(17)製得乳液。 The following components (1) to (9) were heated and mixed to 70 °C. To the mixture, the mixture was mixed and heated at 70 ° C (10) to (13) and (18), cooled, and further mixed (14) to (17) to obtain an emulsion.
(成分) (%) (ingredient) (%)
(1)氫化大豆磷脂 3.0 (1) Hydrogenated soybean phospholipids 3.0
(2)膽固醇 0.2 (2) cholesterol 0.2
(3)聚氧乙烯(5)十六烷基醚 0.2 (3) Polyoxyethylene (5) cetyl ether 0.2
(4)聚氧乙烯(10)氫化蓖麻油 1.0 (4) Polyoxyethylene (10) hydrogenated castor oil 1.0
(5)鯨蠟硬脂醇 2.0 (5) Cetearyl alcohol 2.0
(6)橄欖角鯊烷 5.0 (6) Olive Squalane 5.0
(7)二丙二醇 7.0 (7) Dipropylene glycol 7.0
(8)1,3-丁二醇 5.0 (8) 1,3-butanediol 5.0
(9)於製造例1所得之勞丹酸 0.1 (9) Laudanic acid obtained in Production Example 1 0.1
(10)吡咯啶酮羧酸鈉 0.1 (10) Sodium pyrrolidone carboxylic acid 0.1
(11)三甲基甘胺酸 2.0 (11) Trimethylglycine 2.0
(12)羥丙基甲基纖維素 0.1 (12) Hydroxypropyl methylcellulose 0.1
(13)羧基乙烯聚合物 0.2 (13) Carboxyvinyl polymer 0.2
(14)氫氧化鉀 0.1 (14) Potassium hydroxide 0.1
(15)防腐劑 適量 (15) Preservatives
(16)香料 適量 (16) Spices
(17)二伸乙三胺五乙酸五鈉40%水溶液 0.2 (17) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.2
(18)純水 殘餘量 (18) Pure water residual amount
於將下述成分(13)~(18)加熱混合並在保溫70℃者,加入將成分(1)~(12)同樣加熱混合後之物,然後乳化。於此物加入冷卻後成分(19)~(21),混合均勻後製得乳液。 The following components (13) to (18) were heated and mixed, and when the temperature was kept at 70 ° C, the components (1) to (12) were heated and mixed, and then emulsified. After cooling, the components (19) to (21) after cooling are added, and the mixture is uniformly mixed to prepare an emulsion.
(成分) (%) (ingredient) (%)
(1)去水山梨醇單硬脂酸酯 0.3 (1) sorbitan monostearate 0.3
(2)聚氧乙烯(20)去水山梨糖醇單油酸酯 0.1 (2) Polyoxyethylene (20) sorbitan monooleate 0.1
(3)親油型單硬脂酸甘油酯 0.2 (3) lipophilic glyceryl monostearate 0.2
(4)硬脂酸 0.5 (4) Stearic acid 0.5
(5)鯨蠟醇 0.5 (5) Cetyl alcohol 0.5
(6)角鯊烷 3.0 (6) Squalane 3.0
(7)液態石蠟 4.0 (7) Liquid paraffin 4.0
(8)三-2-乙基己酸甘油酯 2.0 (8) Tris-2-ethylhexanoate 2.0
(9)二甲基聚矽氧烷 1.0 (9) dimethyl polyoxane 1.0
(10)氫化大豆磷脂 0.1 (10) hydrogenated soybean phospholipid 0.1
(11)乙酸-dl-α-生育酚*1 0.05 (11) acetic acid-dl-α-tocopherol*1 0.05
(12)防腐劑 適量 (12) Preservatives
(13)羧基乙烯聚合物 0.1 (13) Carboxyvinyl polymer 0.1
(14)氫氧化鈉 0.05 (14) Sodium hydroxide 0.05
(15)甘油 5.0 (15) Glycerin 5.0
(16)1,3-丁二醇 7.0 (16) 1,3-butanediol 7.0
(17)純水 殘餘量 (17) Pure water residual amount
(18)二伸乙三胺五乙酸五鈉40%水溶液 0.1 (18) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
(19)乙醇 5.0 (19) Ethanol 5.0
(20)於製造例1所得之勞丹酸 0.05 (20) Laudanic acid obtained in Production Example 1
(21)香料 適量 (21) Spices
於將下述成分(1)~(5)及(16)加熱混合並在保溫70℃者,添加混合在70℃下加熱混合後之(6)~(10),然後冷卻至室溫。進一步添加混合(11)~(15)並製得凝膠化妝料。 The following components (1) to (5) and (16) were heated and mixed, and when they were kept at 70 ° C, the mixture was mixed and heated at 70 ° C (6) to (10), and then cooled to room temperature. Further, mixing (11) to (15) was added to prepare a gel cosmetic.
(成分) (%) (ingredient) (%)
(1)甲基纖維素 2.0 (1) Methylcellulose 2.0
(2)黃原膠 1.0 (2) Xanthan gum 1.0
(3)藻酸鈉 0.2 (3) sodium alginate 0.2
(4)烷基改性羧基乙烯聚合物 0.2 (4) Alkyl modified carboxyvinyl polymer 0.2
(5)玻尿酸鈉1%水溶液 2.0 (5) Sodium hyaluronate 1% aqueous solution 2.0
(6)甘油 10.0 (6) Glycerin 10.0
(7)聚乙二醇2000 1.0 (7) Polyethylene glycol 2000 1.0
(8)甲基葡萄糖 2.0 (8) Methyl glucose 2.0
(9)氫化卵黃磷脂 0.2 (9) hydrogenated egg yolk phospholipid 0.2
(10)植物固醇 0.1 (10) Phytosterol 0.1
(11)氫氧化鈉 0.1 (11) Sodium hydroxide 0.1
(12)防腐劑 適量 (12) Preservatives
(13)香料 適量 (13) Spices
(14)於製造例1所得之勞丹酸 0.01 (14) Laudanic acid obtained in Production Example 1
(15)二伸乙三胺五乙酸五鈉40%水溶液 0.05 (15) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.05
(16)純水 殘餘量 (16) pure water residual amount
在70℃下將下述成分(1)~(9)加熱混合,冷卻至室溫。於此混合物中,添加混合(10)、(15)、(16),並進一步添加混合(11)~(14)製得油凝膠化妝料。 The following components (1) to (9) were heated and mixed at 70 ° C, and cooled to room temperature. In this mixture, a mixture of (10), (15), and (16) was added, and further (11) to (14) were added to prepare an oil gel cosmetic.
(成分) (%) (ingredient) (%)
(1)聚氧乙烯(20)聚氧丙烯(4)十六烷基醚 1.0 (1) Polyoxyethylene (20) polyoxypropylene (4) cetyl ether 1.0
(2)聚氧乙烯(20)三異硬脂酸甘油酯 0.2 (2) Polyoxyethylene (20) glyceryl triisostearate 0.2
(3)烷基改性羧基乙烯聚合物 0.2 (3) Alkyl modified carboxyvinyl polymer 0.2
(4)甘油 10.0 (4) Glycerin 10.0
(5)二丙二醇 2.0 (5) Dipropylene glycol 2.0
(6)1,3-丁二醇 5.0 (6) 1,3-butanediol 5.0
(7)聚氧乙烯(10)甲基葡萄糖 0.2 (7) Polyoxyethylene (10) methyl glucose 0.2
(8)三-2-乙基己酸甘油酯 75.0 (8) Tris-2-ethylhexanoic acid glyceride 75.0
(9)角鯊烷 2.0 (9) Squalane 2.0
(10)三乙醇胺 0.1 (10) Triethanolamine 0.1
(11)防腐劑 適量 (11) Preservatives
(12)香料 適量 (12) Spices
(13)二丁基羥基甲苯 0.002 (13) Dibutylhydroxytoluene 0.002
(14)於製造例1所得之勞丹酸 0.03 (14) Laudanic acid obtained in Production Example 1 0.03
(15)二伸乙三胺五乙酸五鈉40%水溶液 0.15 (15) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.15
(16)純水 殘餘量 (16) pure water residual amount
將下述成分(1)~(9)及(12)、(17)混合溶解後,將混合物加入將成分(10)、(11)、(13)~(16)及(18)~(19)混合溶解後之混合物中,藉混合製得化妝水。 After the following components (1) to (9), (12), and (17) are mixed and dissolved, the mixture is added to the components (10), (11), (13) to (16), and (18) to (19). In the mixture after the dissolution, the lotion is prepared by mixing.
(成分) (%) (ingredient) (%)
(1)夏威夷果仁油 0.01 (1) Macadamia Nut Oil 0.01
(2)於製造例1所得之勞丹酸 0.1 (2) Laudanic acid obtained in Production Example 1 0.1
(3)辛酸鯨蠟酯 0.01 (3) Cetyl octanoate 0.01
(4)三-2-乙基己酸甘油酯 0.01 (4) Tris-2-ethylhexanoate glycerin 0.01
(5)乙酸-dl-α-生育酚 0.02 (5) Acetic acid-dl-α-tocopherol 0.02
(6)山梨糖醇倍半油酸酯 0.1 (6) Sorbitol sesquioleate 0.1
(7)聚氧乙烯(20)去水山梨糖醇單油酸酯 0.1 (7) Polyoxyethylene (20) sorbitan monooleate 0.1
(8)聚氧乙烯(8)烷基醚磷酸酯 0.2 (8) Polyoxyethylene (8) alkyl ether phosphate 0.2
(9)乙醇 10.0 (9) Ethanol 10.0
(10)山梨糖醇(70%水溶液) 5.0 (10) Sorbitol (70% aqueous solution) 5.0
(11)甘油 1.0 (11) Glycerin 1.0
(12)2-羥基-4-甲氧二苯甲酮 0.2 (12) 2-hydroxy-4-methoxybenzophenone 0.2
(13)2-羥基-4-甲氧二苯甲酮-5-磺酸鈉 0.2 (13) Sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate 0.2
(14)乳酸(50%水溶液) 0.1 (14) Lactic acid (50% aqueous solution) 0.1
(15)乳酸鈉(50%水溶液) 0.3 (15) Sodium lactate (50% aqueous solution) 0.3
(16)防腐劑 適量 (16) Preservatives
(17)香料 適量 (17) Spices
(18)二伸乙三胺五乙酸五鈉40%水溶液 0.1 (18) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
(19)純水 殘餘量 (19) Pure water residual amount
將成分(1)~(9)混合溶解後之混合物,加入將(10)~(15)混合溶解後之混合物中,藉混合製得化妝水。 The mixture of the components (1) to (9) is mixed and dissolved, and the mixture obtained by mixing and dissolving (10) to (15) is added, and a lotion is prepared by mixing.
(成分) (%) (ingredient) (%)
(1)γ-蔗糖亞麻油酸酯 0.05 (1) γ-sucrose linoleic acid ester 0.05
(2)單異硬脂酸聚氧乙烯(50)氫化蓖麻油 1.0 (2) Monoisostearic acid polyoxyethylene (50) hydrogenated castor oil 1.0
(3)異棕櫚酸L-抗壞血酸 0.1 (3) Isobaronic acid L-ascorbic acid 0.1
(4)聚氧乙烯(10)烷基醚磷酸酯 0.1 (4) Polyoxyethylene (10) alkyl ether phosphate 0.1
(5)辛基甲氧基肉桂酸 0.05 (5) Octylmethoxycinnamic acid 0.05
(6)甘油 3.0 (6) Glycerin 3.0
(7)於製造例1所得之勞丹酸 0.05 (7) Laudanic acid obtained in Production Example 1
(8)1,3-丁二醇 5.0 (8) 1,3-butanediol 5.0
(9)乙醇 8.0 (9) Ethanol 8.0
(10)檸檬酸鈉 0.02 (10) Sodium citrate 0.02
(11)檸檬酸 0.05 (11) Citric acid 0.05
(12)防腐劑 適量 (12) Preservatives
(13)香料 適量 (13) Spices
(14)二伸乙三胺五乙酸五鈉40%水溶液 0.15 (14) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.15
(15)純水 殘餘量 (15) pure water residual amount
將下述成分(1)~(10)混合溶解後之混合物,添加混合入(11)~(16)之混合溶解物製得白濁化妝水。 The mixture of the following components (1) to (10) was mixed and dissolved, and the mixed solution of (11) to (16) was added and mixed to prepare a white turbid lotion.
(成分) (%) (ingredient) (%)
(1)聚氧乙烯(60)氫化蓖麻油 0.7 (1) Polyoxyethylene (60) hydrogenated castor oil 0.7
(2)聚氧乙烯烷基醚磷酸鈉 0.2 (2) Polyoxyethylene alkyl ether sodium phosphate 0.2
(3)膽固醇 0.01 (3) Cholesterol 0.01
(4)氫化卵黃磷脂 0.02 (4) hydrogenated egg yolk phospholipids 0.02
(5)二甲基聚矽氧烷 0.05 (5) dimethyl polyoxane 0.05
(6)乙酸-dl-α-生育酚 0.5 (6) Acetic acid-dl-α-tocopherol 0.5
(7)對甲氧基肉桂酸2-乙基己酯 0.2 (7) 2-ethylhexyl p-methoxycinnamate 0.2
(8)於製造例1所得之勞丹酸 0.1 (8) Laudanic acid obtained in Production Example 1 0.1
(9)乙醇 15.5 (9) Ethanol 15.5
(10)聚乙二醇6000 0.2 (10) Polyethylene glycol 6000 0.2
(11)檸檬酸 0.01 (11) Citric acid 0.01
(12)磷酸一氫二鈉 0.2 (12) Disodium hydrogen phosphate 0.2
(13)防腐劑 適量 (13) Preservatives
(14)香料 適量 (14) Spices
(15)二伸乙三胺五乙酸五鈉40%水溶液 0.2 (15) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.2
(16)純水 殘餘量 (16) pure water residual amount
在70℃下將成分(1)~(7)混合溶解之混合物,與在70℃下將成分(8)~(13)、(17)加溫混合並冷卻至室溫之混合物,與成分(14)~(16)添加混合,製得有黏性的美容液。 The mixture of the components (1) to (7) is mixed and dissolved at 70 ° C, and the mixture of the components (8) to (13), (17) is heated and mixed at 70 ° C and cooled to room temperature, and the components ( 14)~(16) Adding and mixing to make a viscous beauty liquid.
(成分) (%) (ingredient) (%)
(1)異硬脂酸聚氧乙烯(50)氫化蓖麻油 0.2 (1) Iso-stearic acid polyoxyethylene (50) hydrogenated castor oil 0.2
(2)氫化大豆磷脂 0.5 (2) hydrogenated soybean phospholipids 0.5
(3)甘油 7.0 (3) Glycerol 7.0
(4)dl-α-生育酚 0.3 (4) dl-α-tocopherol 0.3
(5)於製造例1所得之勞丹酸 0.05 (5) Laudanic acid obtained in Production Example 1
(6)膽固醇 0.1 (6) Cholesterol 0.1
(7)乙醇 6.0 (7) Ethanol 6.0
(8)2-羥基-4-甲氧二苯甲酮-5-磺酸鈉 0.2 (8) Sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate 0.2
(9)L-抗壞血酸磷酸鎂 0.5 (9) L-ascorbyl magnesium phosphate 0.5
(10)檸檬酸 0.01 (10) Citric acid 0.01
(11)檸檬酸鈉 0.1 (11) Sodium Citrate 0.1
(12)黃原膠 0.1 (12) Xanthan gum 0.1
(13)甲基纖維素 0.1 (13) Methylcellulose 0.1
(14)防腐劑 適量 (14) Preservatives
(15)香料 適量 (15) Spices
(16)二伸乙三胺五乙酸五鈉40%水溶液 1.0 (16) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 1.0
(17)純水 殘餘量 (17) Pure water residual amount
將成分(1)~(10)在室溫下混合,使之分散成泥漿狀。於其中,混合將成分(11)~(16)在室溫下溶解之物,製得防曬乳液。 The components (1) to (10) are mixed at room temperature to be dispersed into a slurry. Among them, a sunscreen lotion was prepared by mixing the components (11) to (16) dissolved at room temperature.
(成分) (%) (ingredient) (%)
(1)二癸酸新戊二醇酯 10.0 (1) Neopentyl glycol diacetate 10.0
(2)對甲氧基肉桂酸2-乙基己酯 5.0 (2) 2-ethylhexyl p-methoxycinnamate 5.0
(3)八甲基環四矽氧烷 10.0 (3) Octamethylcyclotetraoxane 10.0
(4)十甲基環五矽氧烷 10.0 (4) Decamethylcyclopentaoxane 10.0
(5)二甲基聚矽氧烷 5.0 (5) Dimethyl polyoxane 5.0
(6)微粒子氧化鈦 10.0 (6) Microparticle titanium oxide 10.0
(7)微粒子氧化鋅 5.0 (7) Microparticle zinc oxide 5.0
(8)聚烯烴基改性有機聚矽氧烷 5.0 (8) Polyolefin-based modified organopolyoxane 5.0
(9)尼龍粉末 2.0 (9) Nylon powder 2.0
(10)聚乙烯末 1.0 (10) Polyethylene end 1.0
(11)甘油 5.0 (11) Glycerin 5.0
(12)乙醇 5.0 (12) Ethanol 5.0
(13)於製造例1所得之勞丹酸 0.01 (13) Laudanic acid obtained in Production Example 1
(14)防腐劑 適量 (14) Preservatives
(15)二伸乙三胺五乙酸五鈉40%水溶液 0.05 (15) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.05
(16)純水 殘餘量 (16) pure water residual amount
將成分(1)~(9)在70℃下加熱混合。於其中,添 The components (1) to (9) were heated and mixed at 70 °C. Among them, Tim
加混合在50℃下加溫混合之成分(10)~(16),製得油 Adding the mixed ingredients (10) to (16) at 50 ° C to obtain the oil
包水型防曬霜。 Water-based sunscreen.
(成分) (%) (ingredient) (%)
(1)聚氧化烯改性有機聚矽氧烷 2.0 (1) Polyoxyalkylene modified organopolyoxane 2.0
(2)辛基甲氧基棕櫚酸 15.0 (2) Octylmethoxy palmitic acid 15.0
(3)十甲基環五矽氧烷 20.0 (3) Decamethylcyclopentaoxane 20.0
(4)三俞樹酸甘油酯 1.0 (4) Sanshucin glyceride 1.0
(5)微粒子氧化鋅 12.0 (5) Micronized zinc oxide 12.0
(6)微粒子氧化鈦 3.0 (6) Microparticle titanium oxide 3.0
(7)對甲氧基肉桂酸-2-乙基己酯 7.0 (7) p-Methoxycinnamate-2-ethylhexyl acetate 7.0
(8)4-叔丁基-4’-甲氧基二苯酰甲烷 1.0 (8) 4-tert-butyl-4'-methoxydibenzoylmethane 1.0
(9)白蘇油 0.05 (9) Baisu oil 0.05
(10)二丙二醇 5.0 (10) Dipropylene glycol 5.0
(11)乙醇 5.0 (11) Ethanol 5.0
(12)聚乙烯末 3.0 (12) Polyethylene end 3.0
(13)於製造例1所得之勞丹酸 0.05 (13) Laudanic acid obtained in Production Example 1
(14)防腐劑 適量 (14) Preservatives
(15)二伸乙三胺五乙酸五鈉40%水溶液 0.1 (15) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
(16)純水 殘餘量 (16) pure water residual amount
將成分(1)~(8)在70℃下加熱混合,於其中,添加混合在50℃下加溫混合之成分(9)~(16)及(17)~(19),製得油包水型乳霜。 The components (1) to (8) are heated and mixed at 70 ° C, and the components (9) to (16) and (17) to (19) which are heated and mixed at 50 ° C are added thereto to prepare a oil pack. Water cream.
(成分) (%) (ingredient) (%)
(1)氫化大豆磷脂 0.05 (1) Hydrogenated soybean phospholipids 0.05
(2)聚氧化烯改性有機聚矽氧烷 2.0 (2) Polyoxyalkylene modified organopolyoxane 2.0
(3)羥基硬脂酸膽固醇酯 2.0 (3) Cholesteryl hydroxystearate 2.0
(4)膽固醇 2.0 (4) Cholesterol 2.0
(5)角鯊烷 2.0 (5) Squalane 2.0
(6)十甲基環五矽氧烷 7.0 (6) Decamethylcyclopentaoxane 7.0
(7)二異辛酸乙二醇酯 15.0 (7) Diisooctanoic acid glycol ester 15.0
(8)2-羥基-4-甲氧二苯甲酮-5-磺酸鈉 1.0 (8) Sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate 1.0
(9)L-抗壞血酸磷酸鎂 3.0 (9) L-ascorbyl magnesium phosphate 3.0
(10)檸檬酸鈉 0.5 (10) Sodium citrate 0.5
(11)乙二胺四乙酸二鈉 0.05 (11) Disodium edetate 0.05
(12)乙醇 2.0 (12) Ethanol 2.0
(13)1,3-丁二醇 5.0 (13) 1,3-butanediol 5.0
(14)結晶纖維素 2.0 (14) Crystalline cellulose 2.0
(15)球狀尼龍末 1.0 (15) Spherical nylon end 1.0
(16)於製造例1所得之勞丹酸 0.03 (16) Laudanic acid obtained in Production Example 1 0.03
(17)防腐劑 適量 (17) Preservatives
(18)二伸乙三胺五乙酸五鈉40%水溶液 0.1 (18) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
(19)純水 殘餘量 (19) Pure water residual amount
將下述成分(1)~(10)在70℃下加熱混合,於此混合物中,添加混合在70℃下加溫混合之成分(11)~(13)、(20),進一步添加混合成分(14)、~(19),藉由冷卻至室溫製得乳霜。 The following components (1) to (10) are heated and mixed at 70 ° C, and the components (11) to (13) and (20) which are heated and mixed at 70 ° C are added to the mixture, and further, the mixed components are further added. (14), ~(19), obtained by cooling to room temperature to obtain a cream.
(成分) (%) (ingredient) (%)
(1)鯨蠟硬脂醇 3.0 (1) Cetearyl alcohol 3.0
(2)甘油脂肪酸酯 2.0 (2) Glycerol fatty acid ester 2.0
(3)聚氧乙烯(20)去水山梨糖醇單油酸酯 1.0 (3) Polyoxyethylene (20) sorbitan monooleate 1.0
(4)去水山梨醇單硬脂酸酯 1.0 (4) sorbitan monostearate 1.0
(5)N-硬脂醯基-N-甲基牛磺酸鈉 0.5 (5) N-stearyl sulfhydryl-N-methyl taurine sodium 0.5
(6)凡士林 5.0 (6) Vaseline 5.0
(7)二甲基聚矽氧烷 3.0 (7) Dimethyl polyoxane 3.0
(8)三-2-乙基己酸甘油酯 20.0 (8) Tris-2-ethylhexanoic acid glyceride 20.0
(9)於製造例1所得之勞丹酸 0.5 (9) Laudanic acid obtained in Production Example 1 0.5
(10)氧化鈦 0.3 (10) titanium oxide 0.3
(11)二丙二醇 10.0 (11) Dipropylene glycol 10.0
(12)L-抗壞血酸磷酸鎂 3.0 (12) L-ascorbyl magnesium phosphate 3.0
(13)檸檬酸鈉 0.5 (13) Sodium citrate 0.5
(14)甘草酸二鉀 0.1 (14) Dipotassium glycyrrhizinate 0.1
(15)乳酸(50%水溶液) 0.1 (15) Lactic acid (50% aqueous solution) 0.1
(16)乙二胺四乙酸二鈉 0.03 (16) Disodium edetate 0.03
(17)防腐劑 適量 (17) Preservatives
(18)二伸乙三胺五乙酸五鈉40%水溶液 1.0 (18) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 1.0
(19)香料 適量 (19) Spices
(20)純水 殘餘量 (20) pure water residual amount
將下述成分(1)~(6)及(15)在70℃下加熱混合,於冷卻至室溫的混合物中,添加混合成分(7)~(14)製得面膜化妝料。 The following components (1) to (6) and (15) were heated and mixed at 70 ° C, and a mixture of components (7) to (14) was added to the mixture cooled to room temperature to prepare a mask cosmetic.
(成分) (%) (ingredient) (%)
(1)聚乙烯醇 15.0 (1) Polyvinyl alcohol 15.0
(2)甘油 10.0 (2) Glycerin 10.0
(3)聚氧乙烯(10)甲基葡萄糖 3.0 (3) Polyoxyethylene (10) methyl glucose 3.0
(4)三辛酸甘油酯 5.0 (4) Tricaprylin 5.0
(5)聚氧乙烯烷基醚磷酸鈉 1.0 (5) Polyoxyethylene alkyl ether sodium phosphate 1.0
(6)於製造例1所得之勞丹酸 0.1 (6) Laudanic acid obtained in Production Example 1 0.1
(7)乙醇 20.0 (7) Ethanol 20.0
(8)高嶺土 2.0 (8) Kaolin 2.0
(9)氧化鈦 2.0 (9) Titanium oxide 2.0
(10)乳酸(50%水溶液) 0.5 (10) Lactic acid (50% aqueous solution) 0.5
(11)乳酸鈉(50%水溶液) 0.5 (11) Sodium lactate (50% aqueous solution) 0.5
(12)防腐劑 適量 (12) Preservatives
(13)香料 適量 (13) Spices
(14)二伸乙三胺五乙酸五鈉40%水溶液 0.25 (14) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.25
(15)純水 殘餘量 (15) pure water residual amount
於將下述成分(1)~(7)加熱混合,於此混合物中添加成分(13)~(18)混合並在70℃保溫。於將成分(8)~(12)混合並在70℃保溫者中,添加先前的混合物並均勻乳化。冷卻後添加成分(19)~(21)並製得液狀粉底。 The following components (1) to (7) were heated and mixed, and the components (13) to (18) were added to the mixture, and the mixture was kept at 70 °C. In the case where the ingredients (8) to (12) were mixed and kept at 70 ° C, the previous mixture was added and uniformly emulsified. After cooling, components (19) to (21) were added to prepare a liquid foundation.
(成分) (%) (ingredient) (%)
(1)二季戊四醇脂肪酸酯 2.0 (1) Dipentaerythritol fatty acid ester 2.0
(2)液態石蠟 5.0 (2) Liquid paraffin 5.0
(3)硬脂酸 2.0 (3) Stearic acid 2.0
(4)鯨蠟醇 1.0 (4) Cetyl alcohol 1.0
(5)自行乳化之單硬脂酸甘油酯 1.0 (5) Self-emulsified glyceryl monostearate 1.0
(6)對甲氧基肉桂酸2-乙基己酯 8.0 (6) 2-ethylhexyl p-methoxycinnamate 8.0
(7)於製造例1所得之勞丹酸 0.05 (7) Laudanic acid obtained in Production Example 1
(8)甘油 5.0 (8) Glycerin 5.0
(9)三乙醇胺 1.0 (9) Triethanolamine 1.0
(10)羧甲基纖維素 0.2 (10) Carboxymethylcellulose 0.2
(11)膨潤土 0.5 (11) Bentonite 0.5
(12)純水 殘餘量 (12) Pure water residual amount
(13)防腐劑 適量 (13) Preservatives
(14)氧化鈦 6.0 (14) Titanium oxide 6.0
(15)微粒子氧化鈦 2.0 (15) Microparticle titanium oxide 2.0
(16)微粒子氧化鋅 4.0 (16) Microparticle zinc oxide 4.0
(17)雲母 2.0 (17) Mica 2.0
(18)滑石 4.0 (18) Talc 4.0
(19)著色顏料 適量 (19) Coloring pigments
(20)二伸乙三胺五乙酸五鈉40%水溶液 0.15 (20) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.15
(21)香料 適量 (21) Spices
實施例6~20的各種化妝料,皆為經時安定性優異,且藉由施用於皮膚,其防止及改善因日曬等而引起的肌膚的黯沉、斑及雀斑,與因老化而引起的皺紋及鬆弛的效果優異,為可創造具有透明感之美麗肌膚的化妝料。 The various cosmetic materials of Examples 6 to 20 are excellent in stability over time, and are applied to the skin to prevent and improve skin stagnation, plaque, and freckles caused by sun exposure, etc., and cause aging It is excellent in wrinkles and slacks, and is a cosmetic that creates a translucent and beautiful skin.
(處方) (%) (prescription) (%)
1.硬脂酸 5 Stearic acid 5
2.石蠟 殘餘量 2. Paraffin residue
3.二甲基聚矽氧烷(200mm2/s) 0.5 3. Dimethyl polyoxane (200mm 2 / s) 0.5
4.於製造例1所得之勞丹酸 0.1 4. Laudanic acid obtained in Production Example 1 0.1
5.氫化聚異丁烯 5 5. Hydrogenated polyisobutylene 5
6.二伸乙三胺五乙酸五鈉40%水溶液 0.1 6. Diethylenetriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
7.香料 30 7. Spices 30
A.將成分(1)~(4)在110℃下加熱,混合均勻。 A. Heat the ingredients (1) to (4) at 110 ° C and mix well.
B.將(5)~(7)添加於(A)並混和均勻。 B. Add (5) to (7) to (A) and mix well.
C.在減壓下將B脫泡後,在80℃下填充於容器中並冷卻,製得室內芳香劑。 C. After defoaming B under reduced pressure, it was filled in a container at 80 ° C and cooled to prepare an indoor fragrance.
將下述組成之軟膏劑,依以下方法調製。 The ointment of the following composition was prepared in the following manner.
A.將成分(6)~(10)加熱混合,並維持在75℃。 A. The ingredients (6) to (10) were heated and mixed and maintained at 75 °C.
B.將成分(1)~(5)加熱混合,並維持在75℃。 B. The ingredients (1) to (5) were heated and mixed and maintained at 75 °C.
C.將B慢慢加入A,製得軟膏劑。 C. Slowly add B to A to make an ointment.
(成分) (%) (ingredient) (%)
(1)硬脂酸 18.0 (1) Stearic acid 18.0
(2)鯨蠟醇 4.0 (2) Cetyl Alcohol 4.0
(3)乙酸-dl-α-生育酚 0.2 (3) Acetic acid-dl-α-tocopherol 0.2
(4)對羥基苯甲酸甲酯 0.1 (4) Methylparaben 0.1
(5)於製造例1所得之勞丹酸 0.2 (5) Laudanic acid obtained in Production Example 1 0.2
(6)三乙醇胺 2.0 (6) Triethanolamine 2.0
(7)甘油 5.0 (7) Glycerin 5.0
(8)甘草酸二鉀 0.5 (8) Dipotassium glycyrrhizinate 0.5
(9)二伸乙三胺五乙酸五鈉40%水溶液 0.1 (9) Dimethyltriamine pentaacetic acid pentasodium 40% aqueous solution 0.1
(10)純水 殘餘量 (10) Pure water residual amount
實施例21所得之室內芳香劑、實施例22所得之軟膏,皆為勞丹酸之安定性及製劑之安定性優異。 The indoor fragrance obtained in Example 21 and the ointment obtained in Example 22 were all excellent in the stability of the labranic acid and the stability of the preparation.
Claims (7)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2014/058463 WO2015145602A1 (en) | 2014-03-26 | 2014-03-26 | Composition useful as external preparation for skin or cosmetic preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201600116A true TW201600116A (en) | 2016-01-01 |
Family
ID=54194200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104109375A TW201600116A (en) | 2014-03-26 | 2015-03-24 | Composition useful as external preparation for skin or cosmetic preparation |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPWO2015145602A1 (en) |
CN (1) | CN106163489A (en) |
TW (1) | TW201600116A (en) |
WO (1) | WO2015145602A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016218998A1 (en) * | 2016-09-30 | 2018-04-05 | Henkel Ag & Co. Kgaa | improves conditioner hair care products with washout protection |
JP7352489B2 (en) * | 2020-02-26 | 2023-09-28 | 久光製薬株式会社 | Aerosol formulation for massage |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3509897B2 (en) * | 1993-05-28 | 2004-03-22 | 株式会社コーセー | Cosmetics |
JPH07206654A (en) * | 1994-01-14 | 1995-08-08 | Pola Chem Ind Inc | Melanogenesis suppressor and skin external preparation |
JP3836051B2 (en) * | 2001-11-01 | 2006-10-18 | 岩瀬コスファ株式会社 | Skin external preparation containing arbutin |
US20060147397A1 (en) * | 2002-11-07 | 2006-07-06 | Kose Corporation | Composition for preparation for external use on skin and method of using the same |
JP2005008574A (en) * | 2003-06-19 | 2005-01-13 | Takasago Internatl Corp | Collagen production promoter |
JP5955625B2 (en) * | 2012-04-27 | 2016-07-20 | 御木本製薬株式会社 | Skin preparation |
-
2014
- 2014-03-26 CN CN201480077529.1A patent/CN106163489A/en active Pending
- 2014-03-26 JP JP2016509696A patent/JPWO2015145602A1/en active Pending
- 2014-03-26 WO PCT/JP2014/058463 patent/WO2015145602A1/en active Application Filing
-
2015
- 2015-03-24 TW TW104109375A patent/TW201600116A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015145602A1 (en) | 2015-10-01 |
CN106163489A (en) | 2016-11-23 |
JPWO2015145602A1 (en) | 2017-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004041236A1 (en) | Composition for preparation for external use on skin and method of using the same | |
JP2005220084A (en) | Acerola seed extract-containing composition | |
JP6847871B2 (en) | Aqueous solution containing urolithins, a dry solid composition thereof, a method for producing them, and a method for stabilizing urolithins. | |
JP4091824B2 (en) | Skin preparation | |
JP2013112634A (en) | P-menthane-3, 8-diol isomer mixture, composition comprising the same, and product comprising the mixture or composition | |
KR102359729B1 (en) | Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation | |
JP2003048846A (en) | Collagenase inhibitor and antiaging cosmetic | |
JP3987793B2 (en) | Topical skin preparation | |
EP3192493B1 (en) | Moisturizer and cosmetic containing same | |
KR101460777B1 (en) | Cosmetic composition for improving acne | |
TW201600116A (en) | Composition useful as external preparation for skin or cosmetic preparation | |
JP5669437B2 (en) | Composition | |
JP6902329B2 (en) | Inhibitor of sebaceous gland cell activation | |
JP2003160463A (en) | Skin care preparation | |
JP6666737B2 (en) | Composition useful as external preparation for skin or cosmetic | |
JP2013184942A (en) | Antioxidant and dna damage inhibitor | |
JP2011241166A5 (en) | ||
KR20080059820A (en) | Anti-wrinkle agent including camellia oil extract | |
JP2020523291A (en) | Whitening composition containing a novel quercetin compound | |
JP5000964B2 (en) | Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression | |
JP2007153773A (en) | Xanthone derivative, and skin care preparation and pharmaceutical composition each containing the same | |
TW202308591A (en) | Cosmetic | |
JP7030692B2 (en) | Moisturizing composition containing 3-O-galloyl-3,3', 5,5', 7-pentahydroxyflavon | |
JP2006193427A (en) | Hydrogenated retinoids or hydrogenated retinoid derivative and utilization thereof | |
JP2007320851A (en) | Skin care preparation for external use |